Literature DB >> 16151758

[Diagnosis of the "aging male"--what is recommended?].

V S Lenk1.   

Abstract

Aging is a complex process. In males after the 40th year of life the total serum testosterone (T) levels are decreased, especially the serum levels of so-called bioavailable testosterone (BT), whereas the serum levels of sex hormone binding globulin (SHBG) are increased. This androgen deficiency in males does not always cause symptoms. In symptomatic males a detailed history is required supported by screening questionnaires for androgen deficiency, followed by a clinical examination; the serum levels of T and SHBG should also be determined. In patients with normal serum levels of T and increased SHBG serum levels, free testosterone, obtained by calculation from the T and SHBG levels, is a reliable and simple index of BT to show the presence of androgen deficiency. Further endocrinological examinations are only recommended for differential diagnosis in the aging male. Before testosterone replacement therapy is started in symptomatic males with hypogonadism, risk factors, especially cancer of the prostate, have to be excluded.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151758     DOI: 10.1007/s00120-005-0905-6

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  25 in total

1.  Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency?

Authors:  L A J Heinemann; F Saad; K Heinemann; D M Thai
Journal:  Aging Male       Date:  2004-09       Impact factor: 5.892

Review 2.  Clinical review 24: Androgens in the aging male.

Authors:  A Vermeulen
Journal:  J Clin Endocrinol Metab       Date:  1991-08       Impact factor: 5.958

3.  Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men.

Authors:  K W Smith; H A Feldman; J B McKinlay
Journal:  Clin Endocrinol (Oxf)       Date:  2000-12       Impact factor: 3.478

4.  Value of gonadotropin-releasing hormone testing in the differential diagnosis of androgen deficiency in elderly men.

Authors:  M Christ-Crain; C Meier; P R Huber; L Zimmerli; B Mueller
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

5.  Relation of sexual dysfunction to hormone levels, diseases and drugs used in andrological patients.

Authors:  W Krause; H H Müller
Journal:  Urol Int       Date:  2000       Impact factor: 2.089

6.  Differential sex steroid negative feedback regulation of pulsatile follicle-stimulating hormone secretion in healthy older men: deconvolution analysis and steady-state sex-steroid hormone infusions in frequently sampled healthy older individuals.

Authors:  J D Veldhuis; A Iranmanesh; E Samojlik; R J Urban
Journal:  J Clin Endocrinol Metab       Date:  1997-04       Impact factor: 5.958

7.  Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.

Authors:  A Vermeulen; J M Kaufman; V A Giagulli
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

Review 8.  Testosterone, body composition and aging.

Authors:  A Vermeulen; S Goemaere; J M Kaufman
Journal:  J Endocrinol Invest       Date:  1999       Impact factor: 4.256

Review 9.  Impact of obesity on hypogonadism in the andropause.

Authors:  R S Tan; S J Pu
Journal:  Int J Androl       Date:  2002-08

10.  Bioavailable testosterone with age and erectile dysfunction.

Authors:  Akira Tsujimura; Kiyomi Matsumiya; Yasuhiro Matsuoka; Tohru Takahashi; Minoru Koga; Atsushi Iwasa; Masami Takeyama; Akihiko Okuyama
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

View more
  3 in total

Review 1.  [Testosterone substitution therapy in prostate cancer].

Authors:  A Kaminsky; H Sperling
Journal:  Urologe A       Date:  2011-08       Impact factor: 0.639

2.  [Testosterone replacement therapy for prostate cancer].

Authors:  A Kaminsky; H Sperling
Journal:  Urologe A       Date:  2010-01       Impact factor: 0.639

3.  Influence of gender on serum growth hormone, insulin-like growth factor-I and its binding protein-3 during aging.

Authors:  Chiou-Meei Lin; Yeou-Lih Huang; Zu-Yau Lin
Journal:  Yonsei Med J       Date:  2009-06-24       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.